Skip to main content
Erschienen in: Urolithiasis 6/2009

01.12.2009 | Symposium Paper

Pattern of family history in stone patients

verfasst von: Y. M. Fazil Marickar, Abiya Salim, Adarsh Vijay

Erschienen in: Urolithiasis | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Genetic predisposition to urolithiasis is a much discussed topic. The objective of this paper is to identify the types of family members of proved urinary stone patients, who have a history of urinary stone formation. The study population consisted of 2,157 urinary stone patients interviewed in 2003–2007 in the urinary stone clinic. Family members with stone history were classified as group 1—first order single (one person in the immediate family—father, mother, siblings, or children), group 2—first order multiple (more than one member in the above group), group 3—second order single (one person in the blood relatives in family—grandparents, grandchildren, uncles, aunts, cousins, etc.) and group 4—second order multiple (more than one member in the above group). Of the 2,157 patients studied, 349 patients gave positive history of stone disease constituting 16.18%. Of these, 321 were males and 28 were females. Subdivision of the family members showed that 282 patients (80.80%) had single family member with stones and the rest 67 (19.20%) had multiple family members with history of stone disease. Group 1 which constituted one family member in the immediate family had 255 involvements (father: 88, mother: 16, brother: 135, sister: 2, son: 10, and daughter: 4); Group 2 with multiple members in the immediate family constituted 51 relatives; of these, father and brother combination was the most common with 35 occurrences. Group 3 with one person in the distant relatives in family namely grandparents, grand children, uncles, aunts, cousins, etc. constituted 27 occurrences and Group 4 with more than one member in the distant family constituted 16 occurrences. It is concluded that single family member involvement was more than multiple involvements. Males predominated. Stone occurrence was more in the immediate family members than distant relatives. Brothers formed the most common group to be involved with stone disease. Study of stone risk in the family members should be centred on brothers and sons of stone patients.
Literatur
1.
Zurück zum Zitat Ljunghall S, Danielson BG, Fellerstorm B et al (1985) Family history of renal stones in recurrent stone patients. Br J Urol 57:370–374CrossRefPubMed Ljunghall S, Danielson BG, Fellerstorm B et al (1985) Family history of renal stones in recurrent stone patients. Br J Urol 57:370–374CrossRefPubMed
2.
Zurück zum Zitat Ljunghall S (1979) Family history of renal stones in a population study of stone formers and healthy subjects. Br J Urol 51:249–252CrossRefPubMed Ljunghall S (1979) Family history of renal stones in a population study of stone formers and healthy subjects. Br J Urol 51:249–252CrossRefPubMed
3.
Zurück zum Zitat Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8(10):1568–1573PubMed Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8(10):1568–1573PubMed
4.
Zurück zum Zitat Lee YH, Huang WC, Tsai JY et al (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172–177CrossRefPubMed Lee YH, Huang WC, Tsai JY et al (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172–177CrossRefPubMed
5.
Zurück zum Zitat Badr AAY, Hazhir S, Hasanzadeh K (2007) Family history and age at the onset of upper urinary tract calculi. Urol J 4(3):142–145 Badr AAY, Hazhir S, Hasanzadeh K (2007) Family history and age at the onset of upper urinary tract calculi. Urol J 4(3):142–145
6.
Zurück zum Zitat Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW (1999) Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endourol 13(4):313–316CrossRefPubMed Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW (1999) Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endourol 13(4):313–316CrossRefPubMed
7.
Zurück zum Zitat Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti GA (1999) Prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162(1):27–30CrossRefPubMed Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti GA (1999) Prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162(1):27–30CrossRefPubMed
8.
Zurück zum Zitat Trinchieri A, Mandressi A, Luongo P, Coppi F, Pisani E (1988) Familial aggregation of renal calcium stone disease. J Urol 139(3):478–481PubMed Trinchieri A, Mandressi A, Luongo P, Coppi F, Pisani E (1988) Familial aggregation of renal calcium stone disease. J Urol 139(3):478–481PubMed
Metadaten
Titel
Pattern of family history in stone patients
verfasst von
Y. M. Fazil Marickar
Abiya Salim
Adarsh Vijay
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 6/2009
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-009-0214-4

Weitere Artikel der Ausgabe 6/2009

Urolithiasis 6/2009 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.